Ichiyo Shibahara1, Ryuta Saito2, Yoshinari Osada1, Masayuki Kanamori1, Yukihiko Sonoda3, Toshihiro Kumabe4, Shunji Mugikura5, Mika Watanabe6, Teiji Tominaga1. 1. Department of Neurosurgery, Tohoku University School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan. 2. Department of Neurosurgery, Tohoku University School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan. ryuta@nsg.med.tohoku.ac.jp. 3. Department of Neurosurgery, Yamagata University School of Medicine, Yamagata, Japan. 4. Department of Neurosurgery, Kitasato University School of Medicine, Sagamihara, Japan. 5. Department of Diagnostic Radiology, Tohoku University School of Medicine, Sendai, Japan. 6. Department of Pathology, Tohoku University Hospital, Sendai, Japan.
Abstract
PURPOSE: Intracranial glioblastomas with simultaneous spinal lesions prior to chemoradiation therapy or craniotomy, defined as initial spinal metastasis, are not well understood. Herein, we investigated intracranial glioblastoma and demonstrated the importance of spinal screening using gadolinium enhanced spinal magnetic resonance imaging (Gd-MRI). METHODS: Consecutive adult patients with intracranial glioblastoma were treated between 2010 and 2014 and received spinal screening using Gd-MRI. Spinal screening was performed regardless of spine-related symptoms, and patients presenting with and without initial spinal metastasis (spinal and non-spinal groups, respectively) were compared based on patient demographics, tumor characteristics, radiological and molecular features, and overall survival (OS). RESULTS: During the study period, 116 glioblastoma cases were treated and 87 of these (76%) underwent spinal screening. Among these patients, 11 (13%) were included in the spinal group, and 76 (87%) were included in the non-spinal group. All patients of the spinal group were free of symptoms related to spinal lesions. Compared with the non-spinal group, intracranial lesions of the spinal group presented higher incidences of intracranial dissemination and were located at subventricular zones (P = 0.0012 and 0.020, respectively). MIB-1 labeling index, molecular alterations such as IDH1 mutation, TERT promoter mutation, and immunoreactivity of ATRX and MGMT did not differ between two groups. OS was significantly shorter in the spinal group than in the non-spinal group (P = 0.0054). CONCLUSIONS: This study revealed a relatively high incidence of spinal metastasis. A subset of glioblastoma patients benefited from spinal screening, through which early detection of asymptomatic spinal metastasis was achieved.
PURPOSE: Intracranial glioblastomas with simultaneous spinal lesions prior to chemoradiation therapy or craniotomy, defined as initial spinal metastasis, are not well understood. Herein, we investigated intracranial glioblastoma and demonstrated the importance of spinal screening using gadolinium enhanced spinal magnetic resonance imaging (Gd-MRI). METHODS: Consecutive adult patients with intracranial glioblastoma were treated between 2010 and 2014 and received spinal screening using Gd-MRI. Spinal screening was performed regardless of spine-related symptoms, and patients presenting with and without initial spinal metastasis (spinal and non-spinal groups, respectively) were compared based on patient demographics, tumor characteristics, radiological and molecular features, and overall survival (OS). RESULTS: During the study period, 116 glioblastoma cases were treated and 87 of these (76%) underwent spinal screening. Among these patients, 11 (13%) were included in the spinal group, and 76 (87%) were included in the non-spinal group. All patients of the spinal group were free of symptoms related to spinal lesions. Compared with the non-spinal group, intracranial lesions of the spinal group presented higher incidences of intracranial dissemination and were located at subventricular zones (P = 0.0012 and 0.020, respectively). MIB-1 labeling index, molecular alterations such as IDH1 mutation, TERT promoter mutation, and immunoreactivity of ATRX and MGMT did not differ between two groups. OS was significantly shorter in the spinal group than in the non-spinal group (P = 0.0054). CONCLUSIONS: This study revealed a relatively high incidence of spinal metastasis. A subset of glioblastoma patients benefited from spinal screening, through which early detection of asymptomatic spinal metastasis was achieved.
Entities:
Keywords:
Glioblastoma; MRI; Spinal metastasis; Subventricular zone
Authors: Wolfgang Wick; Roger Stupp; Anna-Carina Beule; Jacoline Bromberg; Antje Wick; Ulrike Ernemann; Michael Platten; Christine Marosi; Warren P Mason; Martin van den Bent; Michael Weller; Chris Rorden; Hans-Otto Karnath Journal: Neuro Oncol Date: 2008-07-31 Impact factor: 12.300
Authors: Lily H Kim; Edward H Lee; Michelle Galvez; Murat Aksoy; Stefan Skare; Rafael O'Halloran; Michael S B Edwards; Samantha J Holdsworth; Kristen W Yeom Journal: J Neurosurg Spine Date: 2019-07-05
Authors: Benjamin J Delgado; Leila Moosavi; Ericka Rangel; William Stull; Rahul Dev Polineni; Joseph Chen; Everardo Cobos Journal: J Investig Med High Impact Case Rep Date: 2019 Jan-Dec
Authors: Qiaoli Ma; Felix Schlegel; Samia B Bachmann; Hannah Schneider; Yann Decker; Markus Rudin; Michael Weller; Steven T Proulx; Michael Detmar Journal: Sci Rep Date: 2019-10-15 Impact factor: 4.379